Elite Pharmaceuticals (ELTP)
OTHER OTC:ELTP
US Market
Advertisement

Elite Pharmaceuticals (ELTP) Ratios

Compare
365 Followers

Elite Pharmaceuticals Ratios

ELTP's free cash flow for Q2 2026 was $0.39. For the 2026 fiscal year, ELTP's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
7.23 3.07 2.75 2.82 2.10
Quick Ratio
5.44 2.08 1.53 1.81 1.24
Cash Ratio
2.02 0.54 1.00 1.28 0.55
Solvency Ratio
-0.14 0.83 369.58 1.04 0.66
Operating Cash Flow Ratio
1.77 -0.25 0.43 0.97 0.55
Short-Term Operating Cash Flow Coverage
82.76 -0.76 10.74 18.39 7.77
Net Current Asset Value
$ 40.80M$ 13.94M$ 9.57M$ 8.93M$ 2.16M
Leverage Ratios
Debt-to-Assets Ratio
0.06 0.14 0.10 0.08 0.09
Debt-to-Equity Ratio
0.14 0.20 0.13 0.11 0.15
Debt-to-Capital Ratio
0.12 0.17 0.12 0.10 0.13
Long-Term Debt-to-Capital Ratio
0.06 0.05 0.11 0.05 0.10
Financial Leverage Ratio
2.34 1.45 1.41 1.39 1.62
Debt Service Coverage Ratio
-8.85 4.55 302.38 14.67 10.25
Interest Coverage Ratio
55.01 18.33 1.82K 26.44 8.11
Debt to Market Cap
<0.01 0.05 0.13 0.05 0.04
Interest Debt Per Share
<0.01 0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
-1.06 1.79 -0.61 -0.92 -0.14
Profitability Margins
Gross Profit Margin
55.80%46.55%48.58%45.86%46.76%
EBIT Margin
-0.74%1.86%0.01%15.72%8.29%
EBITDA Margin
1.22%4.56%0.02%19.42%23.36%
Operating Profit Margin
35.50%19.05%5.93%15.72%8.29%
Pretax Profit Margin
-1.39%0.82%11.67%19.54%16.33%
Net Profit Margin
-10.26%35.51%12.91%27.58%20.05%
Continuous Operations Profit Margin
-10.26%35.51%0.01%27.58%20.05%
Net Income Per EBT
738.69%4342.25%110.64%141.14%122.77%
EBT Per EBIT
-3.91%4.29%196.82%124.33%196.93%
Return on Assets (ROA)
11.88%24.04%10783.21%25.32%19.43%
Return on Equity (ROE)
27.95%34.92%15227.43%35.28%31.50%
Return on Capital Employed (ROCE)
39.56%15.28%6125.12%17.82%10.33%
Return on Invested Capital (ROIC)
29.56%619.48%6710.61%22.29%12.32%
Return on Tangible Assets
12.48%26.01%12762.06%31.21%26.02%
Earnings Yield
1.91%12.94%15012.72%25.19%8.99%
Efficiency Ratios
Receivables Turnover
2.91 2.91 11.04K 10.55 7.26
Payables Turnover
9.16 11.15 7.18K 12.21 14.54
Inventory Turnover
2.41 2.34 1.84K 2.59 2.70
Fixed Asset Turnover
7.64 3.88 3.27K 4.62 3.70
Asset Turnover
0.95 0.68 835.17 0.92 0.97
Working Capital Turnover Ratio
1.87 2.79 2.64K 3.48 6.35
Cash Conversion Cycle
213.87 248.59 0.18 145.56 160.57
Days of Sales Outstanding
121.39 125.39 0.03 34.60 50.28
Days of Inventory Outstanding
113.96 155.93 0.20 140.87 135.40
Days of Payables Outstanding
21.48 32.73 0.05 29.90 25.11
Operating Cycle
235.35 281.32 0.23 175.47 185.68
Cash Flow Ratios
Operating Cash Flow Per Share
0.02 >-0.01 <0.01 <0.01 <0.01
Free Cash Flow Per Share
0.02 >-0.01 >-0.01 <0.01 <0.01
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
0.94 1.25 -0.72 0.92 0.90
Dividend Paid and CapEx Coverage Ratio
17.93 -4.05 0.58 13.05 9.68
Capital Expenditure Coverage Ratio
17.93 -4.05 0.58 13.05 9.68
Operating Cash Flow Coverage Ratio
2.86 -0.28 0.86 2.34 1.34
Operating Cash Flow to Sales Ratio
0.18 -0.06 <0.01 0.20 0.13
Free Cash Flow Yield
2.97%-2.63%-8.16%17.01%5.06%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-67.17 7.73 <0.01 3.97 11.12
Price-to-Sales (P/S) Ratio
6.91 2.74 <0.01 1.09 2.23
Price-to-Book (P/B) Ratio
15.24 2.70 1.01 1.40 3.50
Price-to-Free Cash Flow (P/FCF) Ratio
40.41 -37.97 -12.25 5.88 19.76
Price-to-Operating Cash Flow Ratio
38.06 -47.34 8.80 5.43 17.72
Price-to-Earnings Growth (PEG) Ratio
0.44 -0.08 <0.01 0.06 -0.04
Price-to-Fair Value
15.24 2.70 1.01 1.40 3.50
Enterprise Value Multiple
553.60 61.95 3.96 4.72 9.41
Enterprise Value
704.95M 159.99M 25.43M 29.57M 55.77M
EV to EBITDA
32.01 61.95 3.96 4.72 9.41
EV to Sales
5.74 2.83 <0.01 0.92 2.20
EV to Free Cash Flow
32.55 -39.11 -10.60 4.92 19.47
EV to Operating Cash Flow
31.01 -48.76 7.62 4.54 17.46
Tangible Book Value Per Share
0.04 0.05 0.02 0.02 0.01
Shareholders’ Equity Per Share
0.04 0.06 0.03 0.02 0.02
Tax and Other Ratios
Effective Tax Rate
-6.39 -42.42 -0.11 -0.28 -0.23
Revenue Per Share
0.10 0.06 33.72 0.03 0.03
Net Income Per Share
-0.01 0.02 4.35 <0.01 <0.01
Tax Burden
0.59 43.42 1.11 1.41 1.23
Interest Burden
2.80 0.44 781.76 1.24 1.97
Research & Development to Revenue
0.06 0.12 0.18 0.13 0.20
SG&A to Revenue
0.10 0.12 0.15 0.14 0.13
Stock-Based Compensation to Revenue
<0.01 0.15 <0.01 0.02 0.04
Income Quality
1.63 -0.16 0.94 0.73 0.63
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis